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During the course of routine typing of group A streptococci recovered from 
nasopharyngeal cultures of patients suffering from hemolytic streptococcal in- 
fections of the upper respiratory tract, it was noted that, although there was 
no change in the colony morphology on sheep or rabbit blood agar plates, the 
streptococci obtained during convalescence often produced less type-specific M 
substance than  the streptococci isolated during the acute phase of infection. 
It was also observed that the streptococci isolated in the convalescent period 
were often susceptible to the bacteriostatic action of normal children's blood, 
whereas the microorganisms isolated in the early period of the infection were 
invariably resistant. 
These findings  suggested that following infection in man the antigenic com- 
position of the hemolytic streptococcus may undergo changes similar to those 
known to occur in the pneumococcus (1) and diphtheria bacillus (2) following 
natural infections with these bacteria. 
Todd (3) and more recently Ward and Lyons (4) have shown that the ability 
of hemolytic streptococci to multiply in normal human blood is a reliable and 
sensitive method for distinguishing  different strain variants and for determining 
mouse virulence.  Hare (5) has also reported that saprophytic strains of hemo- 
lytic streptococci isolated from the human  birth  canal can be differentiated 
from pathogenic  strains  by their  susceptibility to  the bactericidal  action of 
human blood.  Furthermore, various workers (6-9) have shown that the type- 
specific M antigen is necessary for the exhibition of virulence of group A strepto- 
cocci; and that the presence of this protein antigen characterizes the matt var- 
iant, whereas the glossy variant produces little or no M substance. 
Since previous reports of hemolytic streptococcal variation have been confined 
for the most part to in vitro or animal studies, a similar  study was undertaken 
to investigate this phenomenon during the natural course of infection inman. 
For this purpose the cultures were obtained at weekly intervals from patients 
during the acute, convalescent, and carrier stages of their streptococcal respira- 
tory  infections;  and  the  individual-strains  were  subjected  to  tests  for 
their ability to resist the bacteriostatic action of normal human blood and to 
synthesize the type-specific M protein antigen. 
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Experimental Methods 
The source of the hemolytic streptococcal strains, methods, and preparation 
of material employed was as follows:- 
Hemolytic Streptococci.--The  streptococcal strains were recovered from nose and throat 
cultures of patients with acute hemolytic streptococcal infections of the upper respiratory 
tract at the time of hospital admission and at weekly intervaL~ theres~ter during their hospital 
stay.  In some instances streptococci were not found every week daring the convalescent 
period.  A number of patients received therapeutic doses of sulfadinzine for 7 to 1~: days be- 
tween the 2nd and 4th weeks of illness in an effort to clear up their carrier state; several were 
also treated in a similar manner for purulent complications.  Since this therapy often failed 
to clear the carrier state, subsequent strains were usually obtained from these patients. 
The culture swabs were streaked immediately in duplicate on fresh 5 per cent rabbit  and sheep 
blood agar plates mad incubated at 37°C.  for 18 to 24 hours.  Several representative colonies 
of all hemolytic streptococci were picked and streaked on fresh blood agar plates for further 
identification or transferred directly to broth for serological grouping and typing by the pre- 
cipitin method  (10,  11).  Following isolation and clas~cafion, the hemolytic streptococci 
were immedi~ttely lyophilized. 
To provide uniform handling and to maintain as nearly as possible the original conditions 
of the culture, each strain was taken from the lyophifized stock and subcultured in 45 cc. of 
Todd-Hewitt broth.  Following incubation at 370C. for 16 to 18 hours, the streptococci were 
collected by centrifugntion, resuspended in 2 cc. of fresh broth, and distributed in 0.2 cc. por- 
tions into a series of small glass tubes which were kept in the dry CO2 ice box until used. 
Bactericstasis of Group A Streptococci  in Normal Human Blood.--The details of the method 
to determine the capacity of hemolytic streptococci to resist phagocytosis and multiply in 
normal hum~m blood have been described (12).  In this study no added antibody was em- 
ployed in the bacteriostafic experiments.  The day before each experiment the tubes con- 
raining the series of strai~ obtained from a single patient were thawed from the frozen state, 
a loopful from each was inoculated into 45 cc. of Todd-Hewitt broth, and incubated for 10 to 
12 hours in a water bath at 37°C.  The streptococcal cells were separated by centrifugation 
and resuspended in the original volume of fresh broth.  Tenfold serial dilutions varying from 
10  -1 through 10  "4 were prepared from 1 cc. of each culture for use in the bacteriostatic tests; 
the remainder of the culture was used to prepare the M extracts. 
Titration of Type-Specific M Protein Antigen.--Crude extracts made by heating streptococci 
with hydrochloric acid were prepared as described by Lancefield (10) from each culture studied 
after removal of a sample for use in the bacteriostatic tests described above.  Twofold serial 
dilutions of these extracts in saline were tested with constant smotmts of homologous type- 
specific absorbed rabbit antiserum in capillary pipettes as described by Swift, Wilson, and 
I~mcefield (11).  The titre of the type-specific M  protein antigen was taken as the highest 
dilution of the extract which gave a positive precipitin reaction with the homologous rabbit 
antiserum.  The group-specific C-anti-C reaction was not involved in these titrations, as anti- 
body to the C carbohydrate had been completely removed from the sera by absorption with 
heterologous-type group A streptococcal cells. 
EXPEl~ ~NTAL  RESULTS 
Re~stance  of Straiss te the Ba~teriost~t~ Acti~ of N~r~al Human Blood.-- 
Two  hundred  and fifty-one strains isolated from 54 patients,  who suffered  56 
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bacteriostatic action of normal human blood.  The period of observation for 
each patient ranged from 4 to 55 weeks (average 11 weeks) during which time 
cultures were made at weekly intervals.  From 2 to 15 strains (average 4.5) 
of the same serological type were obtained on culture from each patient follow- 
ing his infection.  Although cultures taken during the 1st week of infection 
were invariably positive for group A  streptococci,  those taken later in con- 
valescence were often negative; and in the case of some patients, many weeks 
separated cultures positive for these microorganisms.  In some instances it is 
not possible, therefore, to state the precise time at which the strains began to 
lose resistance to the bacteriostatic action of normal blood. 
The strains isolated on the initial culture taken within the 1st week of the 
patients' infections always resisted bacteriostasis and multiplied in all dilutions 
of the culture from 10  -1  through  10  -6  .  Such strains are  arbitrarily termed 
"highly resistant."  Strains termed "resistant" signify at least a -bq- diminu- 
tion in growth in the 10-  6 dilution as compared with the corresponding dilution 
of  the  initial  culture;  those  strains  termed  "susceptible"  and  "highly sus- 
ceptible" signify similar diminutions in growth in the 10  -5 and 10  ~  dilutions 
respectively.  Results with this test have been highly reproducible; and we 
believe a -b-k- growth difference in a single dilution is significant.  Some of the 
"highly susceptible" strains showed much greater differences and failed to grow 
in culture dilutions as low as 10--  ~, which is equivalent to the destruction of 100,- 
000 streptococcal cells by 0.25 cc. of normal human blood. 
Resistant strains of streptococci were found throughout the entire period of 
observation among 33, or 59 per cent of the 56 infections studied.  In the first 
part of Table I are recorded the serological types of these resistant strains and 
the last week after infection that each was isolated, which also corresponds to 
the period of observation.  Similar data with regard to the strains which lost 
resistance to bacteriostasis are tabulated in Table II.  From these ddta it is 
apparent that in 23, or 41 per cent, of the infections the strains showed a pro- 
gressive decrease in resistance.  Thus, although the streptococci in the initial 
cultures were always "highly resistant," strains from 13  infections changed 
during the period that the patient was studied to "highly susceptible" to the 
bacteriostatic action of normal human blood; an additional 8 became "suscep- 
tible;" and 2 others became "resistant."  It is also apparent that the time of 
development of this change was variable despite the fact that the exact time 
the change occurred could not always be ascertained.  The change from "highly 
resistant  to  resistant  occurred as early as the 2nd week but was frequently 
noted in the 7th or 8th weeks; the change to "susceptible" took place as early 
as the 2nd week and as late as the 19th week; and in half the cases studied in 
which the strains changed to "highly susceptible," this occurred before the 8th 
week, while in the remainder this degree of change was delayed up to 24 weeks. 
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by their hosts longer than the strains which remained fully resistant to bacterio- 
stasis. 
A  comparison of the length of time that patients with persistently resistant 
strains were studied with the time at which susceptibility first became apparent 
in the susceptible strains shows that the former were observed long enough to 
TABLE I 
Duralion  of Resistance to Bacterios~i$  of Group A  Streptococci Isolated from Patients  at 
Weekly Intervals Following I~ rection* 
Strains losing  resistancet 
Serological 
type 
1 
3 
5 
6 
12 
14 
17 
18 
19 
26 
29 
3O 
32 
33 
38 
Nell, 
1 
3 
1 
2 
2 
1 
1 
14 
Strains maintaining resistance~ 
No. of  Observation  period of patients 
with resistant strains: last wk. in which 
infections  streptococci were isolated 
No. of  1st wk. in which  susceptible 
infections  variants appeared 
5 
5, 11, 13 
7 
10, 26 
4, 4 
7 
5 
5,  5, 5, 6, 6, 6,  7,  7, 8,  11,  12, 
12, 19, 21 
4, 7,8 
20 
6 
5, 18, 20 
2,3 
3, 16 
3, 5, 6 
8 
8 
3, 6, 6, 7, 9, 9, 10 
7, 19, 21 
4 
* Streptococci not obtained on every culture from each patient. 
:~ From 33 patients  (33  infections) 126 strains  isolated  at weekly intervals  maintained 
resistance to bacteriostasis throughout observation period. 
t From 21 patients (23 infections) 125 strains were isolated at weekly intervals:  Susceptible 
variants first appeared at the times indicated. 
1] NC indicates strains not classified with available sera. 
detect such strain variations if they had occurred (Table I).  Some of the resist- 
ant strains were carried in the patient's throat as long as 20 to 26 weeks follow- 
ing the onset of infection, and most of the patients were under observation for 
longer periods  than it  took for variants  to appear in the  series in which the 
streptococci became susceptible.  This comparison is shown in parallel columns 
in Table I.  The majority of the strains which showed lowered resistance de- 
veloped these variants comparatively early: 13 within the first 6 weeks, 9 others 
within 10 weeks, and the remaining 3 within 16, 19, and 21 weeks respectively. SIDNEY ROTIIBARD AND  ROBERT  F. WATSON"  525 
TABLE II 
.Strains of Group A Slreplococci Losing Reslstance to Bacterlost~i¢ Action of Normal 
Children's Blood 
Bacteriostasls of 125 streptococcsl  strains isolated  at weekly  intervals  from 21 patients 
following  23 different  infections* 
SeroloSi-cal  type  Ranesi  ~-  Highly  resistant:  [  [  Susceptible:  ]  I  Highly sttsceptible~: 
Wk. following  infection  streptococci  were isolated 
1 
1 
3 
3 
6 
6 
6 
14 
17 
19 
19 
19 
19 
19 
19 
19 
26 
26 
26 
29 
33 
38 
NC§ 
1,2 
1 
1 
1,2 
1, 2, 4 
1 
1, 2, 3, 4 
1,2,3,4,5,6,7 
1, 2, 3, 4, 5, 6, 7 
1 
1 
i 
1 
1 
1 
1, 5 
1, 2, 3 
1, 
1, 
1, 2, 3 
1 
1 
1 
2, 6, 15 
2, 3, 4, 5, 6 
8 
8  15 
36 
3, 4 
3,4, 5 
6, 10, 16 
3, 4, 5, 6, 8, 10, 14 
5, 6, 7, 9 
9, 10 
17, 20 
9 
10 
9 
19, 23 
7 
3, 5, 7 
2, 3 
6, 7, 8, 9, 10, 11, 12 
16 
4, 5 
20 
11 
24, 28, 51, 55 
6, 7 
6 
21 
8, 14, 19 
4 
2,4,8 
11 
, Streptococci not obtained on every culture from each patient. 
"Highly resistant" signifies resistance to bacteriostasis in aU dilutions of culture from 
10  -1 through  10-'e; "re~stant" signifies  at least a  ++  diminution in growth in the 10  -s 
dilution as compared with the corresponding dilution of the initial culture; "susceptible" 
and "highly susceptible" signify similar diminutions  in growth in the 10  -5 and 10  "~ dilutions 
respectively. 
t NC indicates strains not classified with available sera. 526  VARIATION  IN  GRO'L~  A  STREPTOCOCCI 
Variants were recovered from 9 of 25 patients who received therapeutic doses 
of sulfadiazine for 7 to 14 days in an effort to clear up the carrier state or puru- 
lent complications.  From the remaining 16 patients treated with sulfadiazine, 
only resistant strains were isolated.  Not only did sulfadiazine treatment fail to 
influence the actual number of variants with decreased resistance, but it ap- 
peared to have no relation to the serological types in which these variants oc- 
curred.  Thus 7 of the 9 patients from whom variant strains were obtained were 
infected with type 19 streptococci, one had a type 3, and another a type 26 in- 
fection.  Similarly, patients with consistently resistant strains also  had  in- 
fections with a variety of serological types: 11 had type 19 infections, 2 type 
30, and one each type 6, 18, or 38 infections. 
Although an insufficient number of strains of the various serological types 
were available to determine whether this variation has any relationship to the 
type or is characteristic of particular strains, some of the data may be significant 
in this respect.  Of the 21 series of type 19 strains studied, 20 were isolated from 
individual patients who developed scarlet fever in  the same epidemic  (13). 
In 7 of these 20  patients, type 19 variants which proved susceptible to bac- 
teriostasis appeared during convalescence; while from the remaining 13 patients, 
only resistant strains were isolated during the period of observation.  Although 
in several other types all the strains were on the contrary alike in resistance or 
susceptibility, the numbers in each type were small: the strains recovered from 
the 3 patients with type 26 infections all developed susceptible variants; and 
only resistant strains were recovered from the 3 patients with type 30 infections 
and the 2 patients infected with type 12 streptococci.  In the remaining types 
some strains remained resistant throughout the study of the patient and some 
in each serological type encountered became susceptible.  Consequently, no 
correlation could be established between these strain variations and the sero- 
logical types involved. 
Todd and Lancefield (6) have demonstrated that mouse-virulent matt vari- 
ants of group A streptococci can be converted to mouse-avirulent glossy vari- 
ants  by  repeated  subculture  in  media  containing homologous type-specific 
rabbit antisera.  It appeared of interest, therefore, to determine whether any 
relation existed between the occurrence of variation among these strains and the 
appearance of type-specific antibodies in the sera of patients from whom the 
streptococci were obtained.  In a previous study (14) reported elsewhere, type- 
specific bacteriostatic antibody determinations had been made on the sera of 37 
patients whose series of strains were studied in this present investigation.  Both 
resistant and susceptible strains were found among patients who developed 
bacteriostatic antibodies: 16 patients had resistant strains and 15 had suscep- 
tible strains.  Among the remaining 6 patients with no type-specific antibody 
response,  susceptible variants appeared  in  every case.  It is,  therefore,  ap- 
parent  that  there was no correlation between the appearance of susceptible SIDNEY  ROTHBARD  AND  ROBERT  F.  WATSON  527 
variants and type-specific antibody formation.  Moreover, no correlation was 
found between the time of appearance of the variant strains and the formation 
of antibodies, nor was there any relation between the height of the antibody 
response and the degree of variation.  Apparently, the variation of these strep- 
tococcal strains cannot be explained by the concomitant appearance of type- 
specific bacteriostatic antibodies. 
Since 23 of the 56 streptococcal infections were followed by complications, 
an attempt was made to ascertain whether there was any correlation between 
the appearance of this variation phenomenon and the development of these 
complications, but no such relationship was found.  Of the 23 complicated in- 
fections, strains which showed some degree of variation were recovered from 11 
(3 purulent and 8 rheumatic fever), and only stable strains were isolated from 
the remaining 12 (3 purulent and 9 rheumatic fever).  As far as could be deter- 
mined, the complications appeared in all instances before the isolation of the 
variant strains of streptococci.  From the 33 remaining infections which were 
uncomplicated, 12 yielded strains which showed variation and 21 yielded strains 
which showed no change. 
Relation of the Type-Specific M  Protein Antigen to Bacteriostasis.--In  a pre- 
vious study (12) it has been shown that bacteriostatic susceptible variants pro- 
duce less M protein than do the parent resistant strains.  To determine whether 
this relationship held in the present study, the 251 strains were also tested for 
their capacity to produce the M  protein antigen.  From 4 patients (4 infec- 
tions), 17 strains were not included because they did not fall into known sero- 
logical types.  From the remaining 50 patients with 52 infections, 234 strains 
of known serological types were tested.  In 42 per  cent of the 52 infections, 
strains isolated in the convalescent and carrier stages showed an increasing sus- 
ceptibility to bacteriostasis correlated with a progressive loss of M  substance; 
whereas in the remaining 58 per cent, resistance to bacteriostasis and the capac- 
ity to produce M protein were maintained throughout the observation period. 
In Table III are recorded the results of titration for the M  protein antigen 
prepared from the highly resistant strain recovered on the initial culture and the 
less resistant strain isolated on the last culture.  The streptococcal  extracts 
containing M  protein antigen were diluted in a  twofold serial manner,  and 
tested with type-specific absorbed rabbit antisera.  The data in Table III re- 
veal that the susceptible variant strain in each series produced less M substance 
by at least a  2-tube dilution difference than did the highly resistant parent 
strain; 4 of the strains showed a 4-tube dilution difference; 5, a 5-tube difference; 
2,  a  6-tube and 1,  a  7-tube dilution difference.  Similar titrations were also 
done on each of the series of stable strains which showed no evident variation, 
but these results are  not tabulated because no difference was found in  the 
amount of M substance produced by the strains in each respective series. 
From 3 patients (one with a type 14 infection and 2 with type 26 infections), 528  VARIATION IN  GROUP  A  STREPTOCOCCI 
TABLE HI 
Produc~ion of Type-Spe~if~  M  Substance of Group A  S~reptococd Highly Reslslcnt to 
Bacteriostasis as Compared to Their Susceptible Variants 
Serological type 
1  1 
1  1 
3  1 
3  1 
6  1 
6  1 
6  1 
14  1 
17  1 
19  1 
19  1 
19  1 
19  1 
19  1 
19  1 
19  1 
26  1 
26  1 
26  1 
29  1 
33  1 
38  1 
Bactcriostatlc variant 
Sesceptlble* 
Wk. isolated  M titre~ 
Highly resistant 
Wk. isolated  M titre~ 
1:32 
1:8 
1:16 
t :32 
1:32 
1:16 
1:16 
1:32 
1:16 
1:32 
1:16 
1:32 
1:64 
1:32 
1:32 
1:64 
1:64 
1:64 
1:32 
1:32 
1:32 
1:8 
12 
5 
16 
5 
20 
14 
9 
11 
55 
9 
10 
9 
7 
6 
7 
6 
21 
23 
19 
1:2 
1:1 
1:4 
1:1 
1:4 
1:2 
1:4 
1:4 
1:4 
1:4 
1:8 
1:2 
1:2 
1:2 
1:2 
0 
i:2 
0 
1:1 
1:2 
1:1 
* Indicates variants which show any degree of diminution of resistance from  original 
highly resistant strains. 
Titre signifies highest dilution of type-specific M protein extract which gave a positive 
reaction with homologous rabbit antiserum. 
strains were recovered which were  so degraded  that no M  protein could be 
demonstrated in acid extracts of these variants by the predpitin technique.  It 
is possible that others would have become degraded to a similar degree had the 
patients been followed longer.  In Tables IV a, IV b, and IV c are recorded the SIDNEY  ROTIIBAED  AND  ROBERT  ]~. WATSON  529 
degrees of resistance to bacteriostasis and the M  titre for every strain isolated 
in series from each of these 3 patients.  From Table IV a it is evident that at 
about the 8th week after the onset of a  type 14 infection a  beginning loss of 
resistance to bacteriostasis occurred but with little apparent variation in l~I 
protein synthesis; however, during the 9th week, a further decrease in resistance 
to bacteriostasis occurred and for the first time a definite decrease in the titre of 
M  was noted.  By the llth week there was little resistance to bacteriostasis 
and no M  substance was demonstrable on precipitin test.  After 25 passages 
through mice, the capacity of this degraded var!ant to resist the bacteriostatic 
action of normal human blood and to produce the M  protein substance was 
restored to the levels noted on primary isolation. 
From Tables IV b and IV c it can be seen that strains degraded to a similar 
degree were recovered from the other 2 patients.  Unfortunately the cultures 
taken on one of these patients between the 3rd and 21st week revealed no strep- 
tococci so that the gradual change is not shown in Table IV c.  The most de- 
graded variants in these 2 series also regained after mouse passage their capaci- 
ties to elaborate the M  substance and to resist the bacteriostatic action of hu- 
man blood. 
The series of strains shown in Table IV c is of particular interest because 
special means were available for identification of the variant strain, 24 RS50, 
and  the  original strain,  11 RS50.  This latter strain was unusual in two re- 
spects:  It lacked the T antigen found in most type 26 strains; and it had a pecu- 
liar and characteristic T antigen which has so far not been observed in any other 
strain studied in this laboratory.  Because after an interval of 18 weeks, during 
•  which time no group A streptococci were obtainable on serial weekly cultures, 
the group A streptococci recovered from this patient no longer synthesized type 
26 M  substance,  a  special study was undertaken  to determine whether  the 
peculiar T antigen of the original strain was still present in the later or variant 
strain.  These 2 strains were used to immunize respective groups of rabbits, 
and antibodies specific for the peculiar T antigen of the original strain  11 RS50 
were demonstrated in the sera of both groups of rabbits by direct agglutination 
reactions and specific cross-absorption of the 2 kinds of antisera with  the 2 
strains studied.  Control absorption tests with type 26 strains, which contained 
the usual T antigen of type 26, failed to remove the T antibodies peculiar to the 
RS50 series of strains.  Finding this unusual T antigen in both of these strains 
is additional evidence that the variant strain 24 RS50 was actually a derivative 
of the original strain 11 RS50 isolated from this patient. 
Moreover, by means  of agglutination  tests  with  rabbit  antisera  directed 
toward the type 14 and type 26 T  antigens respectively, it was also possible to 
show that the variants listed in Tables IV a and IV b had the same T  antigens 
as those in the original strains isolated from each of these patients. 
The degraded variants in these 3 series of strains appear to be relatively stable TABLE  IV  a 
Re~tance to Baderlostas~ Correlated u~tk Produd~i,  on of Type-Spedf~¢ M  Proteln Anffgen by Group A 
Type 14 Streptococci  Isolated from a Pa~l  witk Acute Pharyngitis 
Bactericstasis  of streptococcal strains  Titration of type-specific M extract 
Streptococcal 
strain No.  Dilution of culture  Dilution of extract 
10  -1  lO"J  lO-t  10  "~  10-~  10-'  1:1  1:2  1:4  1:8  1:16  1:321:6~[ 
23  RSe4 
RS84 
25  RS84 
26  RSM 
27  RS84 
~8  RSM 
29  RS84 
32  RS84 
33  RSS~ 
34  RS~ 
3~  R584 
&~ RS8~12510* 
4-+++  +4-++  +++4-  +4-+4-  4-+4-  4-+ 
4-+++  +4-++  +++4-  4-+++  4-+4-  +4- 
++++  ++++  +++4-  +++4-  ++4-  +4- 
+4-++  ++++  +4-++  ++++  +++  4-+ 
4-+4-+ 4-+4-+4-+4-+ +4-4-4-  4-4-4-  +4- 
4-4-4-+  4-+4-4- 4-4-+4-  4-4-+4-  4-4-4-++ 
4-++4-  +4-+~  4-++4-  ++++  4-++  ++ 
++4-+ ++++  +++4-  4-+4-  ++  o 
+++4-  +4-++  4-+++  ++~  9  o 
++++  ++4-+  ++4-  4-4-  o  o 
+4-  2  0  0  0  0 
+++4- ++++  ++++  4-+++ 4-++ 4-+ 
4-4-4- 4-+4-  +4-  4-4- 4-4-  +  o 
4-4-4- 4-+4-  +4-  4-4- 4-4-  4-  o 
+4-4-  4-4-4- 4-4- 4-4- 4-+  +  o 
4-4-4- 4-+4-  4-4- 4-+  ++  4-  o 
+++  4-++ ++  4-4-  ++  +  e 
++4- +++  ++  ++  ++  4-  o 
++4-  +4-4-  4-+  4-4-  +4-  4-  o 
4-+-1- 4-4-4- 4-4-  4-4- +4-  +  0 
+4-+  4-++  4-+  +  4-  o  o 
4-++  +++  ++  +  4-  o  e 
0  0  0  0  0  0  0 
++4- ++4- +4- 4-4-  4-4- +  o 
In bscteriostasls  of strains, degree of growth is indicated on a 4-4-4-4- to 4- scale fewe~ than 10 colo~es are represented 
in arabic numerals; 0 indicates no growth. 
In titration  of M antigen, the degree of precipitation  is  indicated on s 4-4-4-4- to 4- scale;  fl reprcsente no precipitstlon. 
* This strain was passed through mice 23 times and regained its capacity to produce the M substance. 
TABLE  IV  b 
Reslstance to Baderiostasis Correlated with Production of Type-Spcdfi¢  M  Protein  Anffgen by Group A 
Type 26 Streptococci Isolated from a Put.at with Acute Pharyngi~s 
Streptococcal 
strain No. 
14 RS15 
15 RS15 
16 RS15 
17 RSI5 
18 RSI5 
19  RS15 
20  RS15 
21 RSI5 
22  RS15 
23  RSI5 
23  RS15/25/O* 
Ser© 
logi, 
¢al 
typq 
26 
26 
26 
26 
26 
26 
26 
26 
26 
26 
Bacteriostasls of streptococcal strains  Titration of type-specific M extract 
Dilutionof~e  Diluti~ofextract 
l~X  l~J  I~  1~  1~s  l~S  1:1  1:2  1:4  1:8  1:16  1:321:~ 
++++  4-+++  ++++  4-+++  4-++++--:++4-  ++  4-4-  4-+  4-4-  4-  o 
++++  +4-+4-  +++4-  +++4-  4-++  ++  i++4-  ++4-  4-+  +4-  4-4-  +  o 
4-++4-  4-4-+4-  +4-+4-  +4-4-+  4-4-4-  4-+  4-4-  4-4-  +4-  4-4-  4-4-  4-  0 
4-+4-4-  4-4-4-4-  4-4-++  +4-+4-  4-4-4-  4-4-  4-4-  4-4-  4-4-  4-4-  4-4-  4-  0 
4-4-++  4-+4-+  +4-4-4-  4-4-4-4-  +4-4-  4-+  ++  ++  4-4-  +4-  4-4-  4- 
4-4-+4- +4-+4- 4-4-4-4-  4-+4-4- +4-  +  4-4-  ++  +4-  +4-  +  4-  o 
+4-4-4-  4-++4-  +4-4-4-  4-+4-4-  4-  8  4-4-  4-4-  4-4-  4-4-  4-  4-  o 
4-4-++  ++4-  ++4-  '++  o  o  4-4-  +4-  4-4-  4-  o  o  o 
4-  7  o  o  o  o  4-  oooooo 
4-  0  0  0  O0  0  000000 
4-4-+4-  4-+++  +4-4-+  4-+4-4-  4-++  +4-  +++++4-  +4-+  4-4-++  4-  0 
Same symbols  for Imcteriostasis  of strains and titration of M antigen as used in Table IV a. 
* This strain was passed through mice 25 times and regained its capacity to produce the M substance. 
TABLE  IV c 
Resisiance 1o Bacier~ostosis  Correlated w@k  P¢od~iou of Type-Specific JW Pro~  A~ig~  by  Group A 
Type 26 S~reptocccci Isolated from a Patient, wilh Acu~ P~o~y~giffs 
Streptococcal 
strain No. 
11 RSs0 
12 RSS0 
13 RS50 
24 RS50 
24  RS50/21/O* 
]$acteriostasis of streptocococc~l strains 
Dilution of culture 
lO-X  lO'-S  10  -'~  I0  -t  lO'-S  10-6 
4-+++  +++4-  ++++  ++4-4-  ++++  +++ 
4-++4-  ++++  +4-+4-  +++4-  +4-+  4-++ 
4-+++  4-4-4-4-  +++4-  ++++  ++4-  ++ 
++++  ++  7  o  o  o 
+4-+4-  +++4-  ++++  ++++  4-++  ++ 
Titration of type-spedfic M extract 
Dilution of extract 
1:1  1:2  1:4  1:81:16  1:32  1:8J, 
+++  +++++-~++  4-  4-  ~- 
++4- 4-4-4-  4-4-  +4-  4-  4-  e 
++4- ++4-  +4-  ++  q-  4-  e 
0  0  0  0  0  0  0 
+4-+ 4-+4-  4-4- 4-+  4-  -',-  0 
Same symbols  for l~cteriostasis  ot strains and titration of M antigen as used in Table IV a. 
* This strain was passed through mice  21 times  and regained its  capacity to produce the M substaace. 
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antigenic.ally since no evidence of spontaneous reversion to  the  original state 
has been noted after several years.  It may also be noteworthy that only 2 of 
the 3 patients from whom these degraded variants were isolated developed type- 
specific bacteriostatic antibodies following infection.  This indicates, as pre- 
viously noted,  that the production of type-specific bacteriostatic  antibodies 
does not explain the variation. 
The colony morphology was carefully investigated on fresh sheep and rabbit 
blood agar plates to see whether any difference could be observed by this means 
between the bacteriostatic-resistant M-producing parent strain  and the de- 
graded  bacteriostatic-susceptible  non-M-producing  variant.  No  significant 
difference was detected, nor was capsule formation of any help in differentiating 
the 2 variants of the various strains. 
In an attempt to explain the loss of M antigen, the variants which completely 
lost their ability to produce M  were repeatedly tested for the production of 
streptococcal proteinase, an extracellular proteolytic enzyme which digests the 
M  protein (15).  This proteolytic enzyme could not be demonstrated in cul- 
tures of any of the parent strains or their variants. 
These data show that group A streptococci may lose their capacity to elabo- 
rate the type-specific M protein antigen and become susceptible to the bacterio- 
static action of human blood while the bacteria are residing in the host's tis- 
sues; but the factor or factors which are responsible for the occurrence of these 
phenomena are still unknown. 
DISCUSSION 
From the evidence presented in this report, it appears that in the course of 
group A streptococcal infections in man, variant strains often occur which are 
characterized by a  decreased capacity to produce the type-specific M protein 
antigen, and a concomitant decrease in resistance to the bacteriostatic action 
of normal human blood.  This variation occurs gradually over a period of weeks 
during convalescence and the carrier period while the streptococci persist in the 
nasopharyngeal tissues of the host.  In the 3 series of strains each characterized 
by the development of variants which lost their capacity to produce the M anti- 
gen, the same T  antigen was retained in each instance as that present in the 
strain originally isolated from the patient.  These degraded variants are rela- 
tively stable since reversion after numerous subcultures on bacteriological media 
has not occurred; the original capacities, however, to produce the M substance 
and to resist bacteriostasis can be restored by serial mouse passage.  Since the 
T antigen was found to be similar in both the variant and original strains, and 
since the M-producing capacity was restored to the variant on mouse passage, 
it appears that these degraded strains were derived from the original strains 
which caused the patient's infection. 
In seeking an explanation for the variation, it was found that its occurrence 532  VARIATION  IN GROUP A  STR~PTOCOCCI 
was not related to the production of type-specific antibody by the host, nor was 
it dependent on the production by the variants of a  proteolyfic enzyme (15) 
which is known to destroy the M protein. 
The possibility that the degraded variants were present at all times during the 
infection and that in convalescence they were selected on culture by chance 
seems very unlikely; nevertheless this must be considered.  The fact that mul- 
tiple colonies picked from a single culture failed to reveal differences in varia- 
tion seems to be against this possibility.  Moreover, the gradual and progres- 
sive changes only in the direction of further degradation also suggest that no 
chance selection occurred. 
The decrease in resistance of streptococcal strains to bacteriostasis by normal 
blood has uniformly been associated with a diminished capacity of the strepto- 
coccal cells to produce the M protein antigen.  The M substance, which is prob- 
ably a surface antigen, has been shown to play an important r61e in the exhi- 
bition  of virulence,  and  in  these  respects  is  analogous to  the  type-specific 
polysaccharide of the pneumococcus.  From the evidence at hand it would 
appear that the M  protein plays an important part in protecting the strepto- 
coccal cell from phagocytosis by the leukocytes of normal blood.  In  some 
instances the decreased resistance to bacteriostasis was evident before a definite 
decrease in the capacity of the streptococcal cells to produce the M protein could 
be demonstrated.  This is probably explained by a difference in the sensitive- 
ness of the two tests: the bacteriostatic test being more sensitive for demon- 
strating a slight loss of the M  substance than the precipitin test. 
Although knowledge of the factor or factors which are responsible for the 
occurrence of variation during the natural course of group A streptococcal in- 
fections remains obscure, there is ample evidence to show that this phenomenon 
does occur frequently enough possibly to be of considerable importance from the 
standpoint  of  preventive  medicine.  There  is  some  evidence  to  indicate 
that certain persons harboring hemolytic streptococci are more likely to dissem- 
inate infection than others (16,  17).  It is possible that among other facto.rs 
which make one host less dangerous than another is the fact that in some the 
strains may undergo variation with an associated decrease in virulence and in-' 
vasiveness. ~ What perhaps is more important is that the majority of strains 
do not lose their capacity to synthesize the M protein for relatively long periods 
after the onset of infection and are therefore potentially dangerous pathogens. 
SD'M~d~Y 
A study was made of the variation occurring in group A streptococci du~ing 
the natural course of infection in man.  From 54 patients with 56 different 
group A streptococcal infections of the upper respiratory tract, 251 strains of 
streptococci, isolated at weekly intervals following infection, were tested for 
their capacity to resist the bacteriostatic action of normal human blood.  In 52 
of the infections the streptococci were of recognized serological types and were SIDNEY  ROTHBARD  AND  ROBERT  1~.  WATSON  533 
also tested for variation in tl~eir ability to produce the type-specific M  protein 
antigen.  Strains isolated in the 1st week of infection were uniformly highly 
resistant to bacteriostasis and elaborated large amounts of M substance.  In 42 
per cent of the 52 infections, strains  isolated in the convalescent and carrier 
stages showed an  increasing  susceptibility to bacteriostasis  correlated with  a 
progressive loss of M substance; whereas in the remaining 58 per cent resistance 
to  bacteriostasis  and  the  capacity  to  produce  M  protein  were  maintained 
throughout the observation period. 
In 3 different infections, the streptococci became so degraded that no NI pro- 
tein could be clemonstrated in acid extracts of these variants.  Concomitantly 
these strains became highly susceptible to bacteriostasis.  Spontaneous rever- 
sion  did  not  occur,  but  serial  mouse passage  reestablished  these  functions. 
These degraded variants had the same T  antigen as  their  respective  original 
strains. 
No evidence was obtained that variation of group A streptococci in resistance 
to bacteriostasis or in the ability to produce the type-specific M  antigen was 
associated  (a)  with  the appearance  of type-specific bacteriostatic  antibodies; 
(b) with any particular  serological type of streptococcus; (c) with the produc- 
tion of streptococcal proteinase which digests the M protein; (d) with the thera- 
peutic administration  of sulfadiazine; or (e) with the development of complica- 
tions. 
The possible relationship of these observations to the problem of the "dan- 
gerous carrier" of group A hemolytic streptococci is discussed. 
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